SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3v4o'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_A_CHDA1501_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.38A	1hrkA-3v4oA: 2.3	1hrkA-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_B_CHDB2501_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.48A	1hrkB-3v4oA: 2.9	1hrkB-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C12_C_SPMC1434_1 (NITROALKANE OXIDASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 519 VAL A 380 ALA A 345 LEU A 369 VAL A 366	None	1.15A	2c12C-3v4oA: undetectable	2c12C-3v4oA: 21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C12_C_SPMC1434_1 (NITROALKANE OXIDASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	VAL A 380 ALA A 345 LEU A 346 LEU A 369 VAL A 366	None	1.05A	2c12C-3v4oA: undetectable	2c12C-3v4oA: 21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C12_F_SPMF1433_1 (NITROALKANE OXIDASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 346 VAL A 442 LEU A 446 MET A 449 LEU A 410	None	1.31A	2c12F-3v4oA: undetectable	2c12F-3v4oA: 21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_A_CHDA701_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.17A	2hrcA-3v4oA: undetectable	2hrcA-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_B_CHDB1605_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.15A	2hrcB-3v4oA: 2.2	2hrcB-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PNJ_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.32A	2pnjB-3v4oA: 3.1	2pnjB-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PNJ_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380	None	1.28A	2pnjB-3v4oA: 3.1	2pnjB-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO5_A_CHDA501_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.49A	2po5A-3v4oA: 2.1	2po5A-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO5_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 515 PHE A 511 LEU A 369 VAL A 380 VAL A 458	None	1.17A	2po5B-3v4oA: 3.1	2po5B-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO7_A_CHDA501_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.44A	2po7A-3v4oA: 2.9	2po7A-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO7_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380	None	1.16A	2po7B-3v4oA: 2.7	2po7B-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6F_C_010C6_0 (INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE N-[(5-METHYLISOXAZOL -3-YL)CARBONYL]ALANY L-L-VALYL-N~1~-((1R, 2Z)-4-(BENZYLOXY)-4- OXO-1-{[(3R)-2-OXOPY RROLIDIN-3-YL]METHYL }BUT-2-ENYL)-L-LEUCI NAMIDE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	3 / 3	ASN A 350 LEU A 359 HIS A 415	None	0.68A	2q6fB-3v4oA: undetectable	2q6fB-3v4oA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_A_CHDA801_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 VAL A 380 VAL A 458	None	0.97A	2qd4A-3v4oA: 2.3	2qd4A-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_B_CHDB928_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 376 LEU A 519 GLN A 337 LEU A 529 VAL A 532	None	1.19A	2qd4B-3v4oA: 3.1	2qd4B-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_B_CHDB928_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 VAL A 380 VAL A 458	None	0.97A	2qd4B-3v4oA: 3.1	2qd4B-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RCT_A_RTLA140_0 (RETINOL-BINDING PROTEIN II, CELLULAR)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	ALA A 498 ARG A 465 VAL A 458 LEU A 461 LEU A 369	None	1.38A	2rctA-3v4oA: undetectable	2rctA-3v4oA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AQI_A_CHDA1_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.21A	3aqiA-3v4oA: 2.2	3aqiA-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AQI_B_CHDB6_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.18A	3aqiB-3v4oA: undetectable	3aqiB-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AQI_B_CHDB6_0 (FERROCHELATASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380	None	1.25A	3aqiB-3v4oA: undetectable	3aqiB-3v4oA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQ7_B_DX2B271_1 (PTERIDINE REDUCTASE 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 8	ARG A 392 PHE A 424 ASP A 471 TYR A 417	None	1.13A	3jq7B-3v4oA: 5.3	3jq7B-3v4oA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_A_DX4A270_0 (PTERIDINE REDUCTASE 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	None	1.11A	3jqaA-3v4oA: 5.4	3jqaA-3v4oA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_B_DX4B270_0 (PTERIDINE REDUCTASE 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	None	1.11A	3jqaB-3v4oA: 5.5	3jqaB-3v4oA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_C_DX4C270_0 (PTERIDINE REDUCTASE 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	None	1.08A	3jqaC-3v4oA: 5.6	3jqaC-3v4oA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_D_DX4D270_0 (PTERIDINE REDUCTASE 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	None	1.06A	3jqaD-3v4oA: 5.4	3jqaD-3v4oA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JW5_B_TOPB208_1 (DIHYDROFOLATE REDUCTASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 10	ALA A 345 LEU A 369 LEU A 460 VAL A 458 LEU A 528	None	1.18A	3jw5B-3v4oA: 2.2	3jw5B-3v4oA: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PS9_A_SAMA670_1 (TRNA 5-METHYLAMINOMETHYL- 2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	GLY A 405 THR A 454 LEU A 402 ASP A 342	None	1.02A	3ps9A-3v4oA: 2.8	3ps9A-3v4oA: 16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_A_CHDA1502_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.45A	3w1wA-3v4oA: 2.2	3w1wA-3v4oA: 19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.21A	3w1wB-3v4oA: 2.3	3w1wB-3v4oA: 19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380	None	1.24A	3w1wB-3v4oA: 2.3	3w1wB-3v4oA: 19.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4I1R_A_LZUA801_1 (MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	7 / 12	VAL A 344 LEU A 346 LYS A 379 VAL A 381 ALA A 394 GLU A 397 PHE A 398	None	0.80A	4i1rA-3v4oA: 30.6	4i1rA-3v4oA: 94.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4I1R_A_LZUA801_1 (MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	8 / 12	VAL A 344 LEU A 346 VAL A 381 ALA A 394 GLU A 397 PHE A 398 LEU A 400 LEU A 401	None	0.80A	4i1rA-3v4oA: 30.6	4i1rA-3v4oA: 94.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y8W_C_STRC603_1 (CYTOCHROME P450 21-HYDROXYLASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 VAL A 487 ILE A 550 ILE A 525 LEU A 369	None	0.94A	4y8wC-3v4oA: undetectable	4y8wC-3v4oA: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HNW_B_TA1B902_1 (TUBULIN BETA-2B CHAIN)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	GLU A 500 LEU A 372 LEU A 515 LEU A 369 THR A 370 PRO A 362	None	1.47A	5hnwB-3v4oA: 2.6	5hnwB-3v4oA: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND3_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	GLU A 500 LEU A 372 LEU A 515 THR A 370 PRO A 362	None	1.16A	5nd3B-3v4oA: 3.3	5nd3B-3v4oA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WEA_A_IPHA901_0 (PROTEIN ARGONAUTE-2)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 5	LEU A 409 TYR A 407 LYS A 343 LEU A 560	None	1.23A	5weaA-3v4oA: 3.6	5weaA-3v4oA: 14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AF6_A_GLYA507_0 (L-PROLYL-[PEPTIDYL-C ARRIER PROTEIN] DEHYDROGENASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	3 / 3	TYR A 434 HIS A 415 MET A 463	None	1.07A	6af6A-3v4oA: undetectable	6af6A-3v4oA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C2M_B_SUEB1202_1 (NS3 PROTEASE)	3v4o	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 9	VAL A 406 ASP A 342 LEU A 410 VAL A 381 SER A 382	None	1.34A	6c2mB-3v4oA: undetectable	6c2mB-3v4oA: 15.10

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HRK_A_CHDA1501_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.38A","1hrkA-3v4oA:2.3","1hrkA-3v4oA:19.07"],["1HRK_B_CHDB2501_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.48A","1hrkB-3v4oA:2.9","1hrkB-3v4oA:19.07"],["2C12_C_SPMC1434_1","NITROALKANE OXIDASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 519;VAL A 380;ALA A 345;LEU A 369;VAL A 366","None","1.15A","2c12C-3v4oA:undetectable","2c12C-3v4oA:21.53"],["2C12_C_SPMC1434_1","NITROALKANE OXIDASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"VAL A 380;ALA A 345;LEU A 346;LEU A 369;VAL A 366","None","1.05A","2c12C-3v4oA:undetectable","2c12C-3v4oA:21.53"],["2C12_F_SPMF1433_1","NITROALKANE OXIDASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 346;VAL A 442;LEU A 446;MET A 449;LEU A 410","None","1.31A","2c12F-3v4oA:undetectable","2c12F-3v4oA:21.53"],["2HRC_A_CHDA701_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.17A","2hrcA-3v4oA:undetectable","2hrcA-3v4oA:19.07"],["2HRC_B_CHDB1605_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.15A","2hrcB-3v4oA:2.2","2hrcB-3v4oA:19.07"],["2PNJ_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.32A","2pnjB-3v4oA:3.1","2pnjB-3v4oA:19.07"],["2PNJ_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380","None","1.28A","2pnjB-3v4oA:3.1","2pnjB-3v4oA:19.07"],["2PO5_A_CHDA501_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.49A","2po5A-3v4oA:2.1","2po5A-3v4oA:19.07"],["2PO5_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;VAL A 380;VAL A 458","None","1.17A","2po5B-3v4oA:3.1","2po5B-3v4oA:19.07"],["2PO7_A_CHDA501_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.44A","2po7A-3v4oA:2.9","2po7A-3v4oA:19.07"],["2PO7_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380","None","1.16A","2po7B-3v4oA:2.7","2po7B-3v4oA:19.07"],["2Q6F_C_010C6_0","INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE;N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",3,"ASN A 350;LEU A 359;HIS A 415","None","0.68A","2q6fB-3v4oA:undetectable","2q6fB-3v4oA:21.84"],["2QD4_A_CHDA801_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;VAL A 380;VAL A 458","None","0.97A","2qd4A-3v4oA:2.3","2qd4A-3v4oA:19.07"],["2QD4_B_CHDB928_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 376;LEU A 519;GLN A 337;LEU A 529;VAL A 532","None","1.19A","2qd4B-3v4oA:3.1","2qd4B-3v4oA:19.07"],["2QD4_B_CHDB928_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;VAL A 380;VAL A 458","None","0.97A","2qd4B-3v4oA:3.1","2qd4B-3v4oA:19.07"],["2RCT_A_RTLA140_0","RETINOL-BINDING PROTEIN II, CELLULAR","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"ALA A 498;ARG A 465;VAL A 458;LEU A 461;LEU A 369","None","1.38A","2rctA-3v4oA:undetectable","2rctA-3v4oA:20.00"],["3AQI_A_CHDA1_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.21A","3aqiA-3v4oA:2.2","3aqiA-3v4oA:19.07"],["3AQI_B_CHDB6_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.18A","3aqiB-3v4oA:undetectable","3aqiB-3v4oA:19.07"],["3AQI_B_CHDB6_0","FERROCHELATASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380","None","1.25A","3aqiB-3v4oA:undetectable","3aqiB-3v4oA:19.07"],["3JQ7_B_DX2B271_1","PTERIDINE REDUCTASE 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","None","1.13A","3jq7B-3v4oA:5.3","3jq7B-3v4oA:21.52"],["3JQA_A_DX4A270_0","PTERIDINE REDUCTASE 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","None","1.11A","3jqaA-3v4oA:5.4","3jqaA-3v4oA:21.52"],["3JQA_B_DX4B270_0","PTERIDINE REDUCTASE 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","None","1.11A","3jqaB-3v4oA:5.5","3jqaB-3v4oA:21.52"],["3JQA_C_DX4C270_0","PTERIDINE REDUCTASE 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","None","1.08A","3jqaC-3v4oA:5.6","3jqaC-3v4oA:21.52"],["3JQA_D_DX4D270_0","PTERIDINE REDUCTASE 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","None","1.06A","3jqaD-3v4oA:5.4","3jqaD-3v4oA:21.52"],["3JW5_B_TOPB208_1","DIHYDROFOLATE REDUCTASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"ALA A 345;LEU A 369;LEU A 460;VAL A 458;LEU A 528","None","1.18A","3jw5B-3v4oA:2.2","3jw5B-3v4oA:19.92"],["3PS9_A_SAMA670_1","TRNA 5-METHYLAMINOMETHYL-2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"GLY A 405;THR A 454;LEU A 402;ASP A 342","None","1.02A","3ps9A-3v4oA:2.8","3ps9A-3v4oA:16.74"],["3W1W_A_CHDA1502_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.45A","3w1wA-3v4oA:2.2","3w1wA-3v4oA:19.12"],["3W1W_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.21A","3w1wB-3v4oA:2.3","3w1wB-3v4oA:19.12"],["3W1W_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380","None","1.24A","3w1wB-3v4oA:2.3","3w1wB-3v4oA:19.12"],["4I1R_A_LZUA801_1","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",7,"VAL A 344;LEU A 346;LYS A 379;VAL A 381;ALA A 394;GLU A 397;PHE A 398","None","0.80A","4i1rA-3v4oA:30.6","4i1rA-3v4oA:94.29"],["4I1R_A_LZUA801_1","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",8,"VAL A 344;LEU A 346;VAL A 381;ALA A 394;GLU A 397;PHE A 398;LEU A 400;LEU A 401","None","0.80A","4i1rA-3v4oA:30.6","4i1rA-3v4oA:94.29"],["4Y8W_C_STRC603_1","CYTOCHROME P450 21-HYDROXYLASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;VAL A 487;ILE A 550;ILE A 525;LEU A 369","None","0.94A","4y8wC-3v4oA:undetectable","4y8wC-3v4oA:19.80"],["5HNW_B_TA1B902_1","TUBULIN BETA-2B CHAIN","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"GLU A 500;LEU A 372;LEU A 515;LEU A 369;THR A 370;PRO A 362","None","1.47A","5hnwB-3v4oA:2.6","5hnwB-3v4oA:20.04"],["5ND3_B_TA1B601_1","TUBULIN BETA-2B CHAIN","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"GLU A 500;LEU A 372;LEU A 515;THR A 370;PRO A 362","None","1.16A","5nd3B-3v4oA:3.3","5nd3B-3v4oA:20.00"],["5WEA_A_IPHA901_0","PROTEIN ARGONAUTE-2","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"LEU A 409;TYR A 407;LYS A 343;LEU A 560","None","1.23A","5weaA-3v4oA:3.6","5weaA-3v4oA:14.55"],["6AF6_A_GLYA507_0","L-PROLYL-[PEPTIDYL-CARRIER PROTEIN] DEHYDROGENASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",3,"TYR A 434;HIS A 415;MET A 463","None","1.07A","6af6A-3v4oA:undetectable","6af6A-3v4oA:21.52"],["6C2M_B_SUEB1202_1","NS3 PROTEASE","3v4o","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"VAL A 406;ASP A 342;LEU A 410;VAL A 381;SER A 382","None","1.34A","6c2mB-3v4oA:undetectable","6c2mB-3v4oA:15.10"]]